Active ingredients: idarubicin
What it is used for
ZAVEDOS is indicated for the use in acute myelogenous leukaemia (AML) in adults for remission induction in untreated patients or for remission induction in relapsed or refractory patients. ZAVEDOS capsules are indicated whenever the intravenous route is not considered suitable. ZAVEDOS may be used in combination chemotherapy regimens involving other cytotoxic agents.
How to take it
The way to take this medicine is: Oral. This medicine is taken by mouth.
- Store below 25 degrees Celsius
- Shelf lifetime is 3 Years.
Always read the label. If symptoms persist see your healthcare professional.
Hard gelatin capsule, self-locking, with opaque red-orange cap & body, size No.4, with a radial imprint on the cap "idarubicin 5" with black ink. The capsules contain an orange powder.
Images are the copyright of the Pharmacy Guild of Australia
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient idarubicin
Consumer Medicines Information (CMI)
For side effects, taking other medicines and more
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems